Travere Therapeutics, Inc. (TVTX) Profit Margin
Travere Therapeutics, Inc. (TVTX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -35.78% |
| 2017-12-31 | -38.76% |
| 2018-12-31 | -62.51% |
| 2019-12-31 | -83.51% |
| 2020-12-31 | -85.43% |
| 2021-12-31 | -79.16% |
| 2022-12-31 | -254.41% |
| 2023-12-31 | -76.70% |
| 2024-12-31 | -137.90% |
| 2025-12-31 | -5.21% |
How TVTX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| AKBA | Akebia Therapeutics Inc. | -2.26% |
| INNV | InnovAge Holding Corp. | -3.55% |
| AXGN | Axogen Inc. | -6.97% |
| RMTI | Rockwell Medical Inc. | -7.67% |
| NTRA | Natera Inc. | -9.03% |
These are five companies in the same sector as TVTX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Travere Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("TVTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TVTX | $65.96 | +3.22% | 1.52M |
| 3 | ||||
| 4 | ||||
| 5 |